These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24962806)

  • 41. Neutrophils Are Critical for Myelin Removal in a Peripheral Nerve Injury Model of Wallerian Degeneration.
    Lindborg JA; Mack M; Zigmond RE
    J Neurosci; 2017 Oct; 37(43):10258-10277. PubMed ID: 28912156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo assessment of peripheral nerve regeneration by diffusion tensor imaging.
    Morisaki S; Kawai Y; Umeda M; Nishi M; Oda R; Fujiwara H; Yamada K; Higuchi T; Tanaka C; Kawata M; Kubo T
    J Magn Reson Imaging; 2011 Mar; 33(3):535-42. PubMed ID: 21287654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
    Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
    Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration.
    Perrin FE; Lacroix S; Avilés-Trigueros M; David S
    Brain; 2005 Apr; 128(Pt 4):854-66. PubMed ID: 15689362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.
    Park HT; Kim YH; Lee KE; Kim JK
    Cell Mol Life Sci; 2020 Jul; 77(13):2497-2506. PubMed ID: 31884566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic swelling and abnormal myelination during secondary degeneration after partial injury to a central nervous system tract.
    Payne SC; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    J Neurotrauma; 2011 Jun; 28(6):1077-88. PubMed ID: 21381867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation.
    Stoll G; Griffin JW; Li CY; Trapp BD
    J Neurocytol; 1989 Oct; 18(5):671-83. PubMed ID: 2614485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axon reactions precede demyelination in experimental models of multiple sclerosis.
    Zapryanova E; Sotnikov OS; Sergeeva SS; Deleva D; Filchev A; Sultanov B
    Neurosci Behav Physiol; 2004 May; 34(4):337-42. PubMed ID: 15341209
    [No Abstract]   [Full Text] [Related]  

  • 49. Axonal pathology in myelin disorders.
    Bjartmar C; Yin X; Trapp BD
    J Neurocytol; 1999; 28(4-5):383-95. PubMed ID: 10739578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination.
    Griffin JW; George R; Lobato C; Tyor WR; Yan LC; Glass JD
    J Neuroimmunol; 1992 Oct; 40(2-3):153-65. PubMed ID: 1430148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
    Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
    J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TUBULAR ARRAYS DERIVED FROM MYELIN BREAKDOWN DURING WALLERIAN DEGENERATION OF PERIPHERAL NERVE.
    THOMAS PK; SHELDON H
    J Cell Biol; 1964 Sep; 22(3):715-8. PubMed ID: 14206434
    [No Abstract]   [Full Text] [Related]  

  • 53. Functional and morphological assessment of a standardized rat sciatic nerve crush injury with a non-serrated clamp.
    Varejão AS; Cabrita AM; Meek MF; Bulas-Cruz J; Melo-Pinto P; Raimondo S; Geuna S; Giacobini-Robecchi MG
    J Neurotrauma; 2004 Nov; 21(11):1652-70. PubMed ID: 15684656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.
    Griffin JW; Li CY; Ho TW; Xue P; Macko C; Gao CY; Yang C; Tian M; Mishu B; Cornblath DR
    Brain; 1995 Jun; 118 ( Pt 3)():577-95. PubMed ID: 7600080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral nerve lesions in a case of equine motor neuron disease.
    Furuoka H; Hasegawa M; Kobayashi Y; Matsui T
    J Vet Med Sci; 1999 May; 61(5):557-60. PubMed ID: 10379951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging.
    Sun SW; Liang HF; Cross AH; Song SK
    Neuroimage; 2008 Mar; 40(1):1-10. PubMed ID: 18187343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wallerian degeneration and axonal regeneration after sciatic nerve crush are altered in ICAM-1-deficient mice.
    Kirsch M; Campos Friz M; Vougioukas VI; Hofmann HD
    Cell Tissue Res; 2009 Oct; 338(1):19-28. PubMed ID: 19657676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of axon-sheath relations during early Wallerian degeneration.
    Friede RL; Martinez AJ
    Brain Res; 1970 Apr; 19(2):199-212. PubMed ID: 4315394
    [No Abstract]   [Full Text] [Related]  

  • 60. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.